Construction and Validation of Alternative Biomarker Immunohistochemistry Assays on the Path to Companion Diagnostics

Posters Nov 7, 2026

Histopathology, IHC

November 7, 2026

Posters

Nov 7, 2026

Spatial immune architecture and tumor–T cell proximity are associated with response to neoadjuvant atezolizumab in muscle-invasive bladder cancer

Posters

Nov 7, 2026

Implementation and cross-validation of a Lunaphore COMET hyperplex assay within a global CRO infrastructure

AAPS PharmSci 360 Role Of Housekeeping Proteins In PBMC Fit For Purpose Validation PARK7 T1530 06 34 1024x791

Posters

Oct 27, 2026

Role of Housekeeping Proteins in PBMC Fit-for-Purpose Validation: PARK7 Reveals Lysis-Dependent Bias in BRD4 Quantification by Mass Spectrometry

CellCarta has the multi-modal capabilities, scientific depth, and harmonized global footprint needed to advance even the most complex programs in precision medicine.

Construction and Validation of Alternative Biomarker Immunohistochemistry Assays on the Path to Companion Diagnostics

Featured Resources

Spatial immune architecture and tumor–T cell proximity are associated with response to neoadjuvant atezolizumab in muscle-invasive bladder cancer

Implementation and cross-validation of a Lunaphore COMET hyperplex assay within a global CRO infrastructure

Role of Housekeeping Proteins in PBMC Fit-for-Purpose Validation: PARK7 Reveals Lysis-Dependent Bias in BRD4 Quantification by Mass Spectrometry

One global CRO for your whole therapeutic development journey